1. Update on Global Fund ATM
Indonesia Country Coordinating Mechanism
24 April 2018
Rejuvenated  40% CCM members are new (April 2017)
Trained New CCM Members (May 2017)
Completed Country Proposal for Grant (July 2017)
Negotiated Grant (September 2017)
Dr. Donald Pardede MPPM – Chairperson CCM Indonesia

2. Global Fund Grant (2018-2020) GoI funding: 26% for TB 25% for HIVAIDS 75% for Malaria
Of the total Grant GF ATM included GoI funding (Co-funding)
Catalytic funding USD 15 M
TOTAL: USD 264,225,834
HIV-AIDS  USD 92 M (Allocated) + USD 4 M (Catalytic)
TB  USD 102 M (Allocated) + USD 15 M (Catalytic)
Malaria  USD 53 (Allocated)

3. Impact / Outcome expected by 2020
HIV TB
Malaria
40% ART coverage
90% ART
12-month retention
240/100K case notification rate
90% treatment success
65-75% MDR treatment success
0.53 positive cases per 1K
>70% districts in Eliminated stage
<2% Endemic districts
85% LLIN ownership and usage
Current CNR ~138 (source: Global TB report 2017)
Current confirmed malaria cases per 1K ~0.84 per 1K
Lower
Not meet global target HIV

4. Current Status HIV-AIDS by end of 2017
HIV-AIDS still a “real threat” with less than 50% health facilities can do Test & Treat hence the target MAY NOT be met by 2030.
Program “outreach” must be improved because positivity rate is too small for new cases, and among pregnant women and TB patient.
Tested 2,561,698 HIV suspects (76% of all outreach); found 48,300 new HIV+ (1,8% positivity rate), making a cumulative 275,987 HIV+ by end of or 43,9% of estimated HIV ; and 91,369 are on ART (33%)
Tested 1,357,255 pregnant women; found 3873 HIV+ (0.28% positivity rate) or 21% out of 17,921 estimated pregnancy with HIV.
Tested 132,049 TB patients and found 6218 (4,7%) HIV positive.
ARV fully provided by GoI and Logistics system is good, with strong routine CSO co-monitoring and NO stock-out reports in 2017

5. Current Status Tuberculosis by end 2017
Without very strong extra efforts and innovative approaches, TB elimination target will NOT be met by 2030.
TB is a “real big threat” with 680,000 new regular cases/year, and high missing cases and only 40% of MDR notified
Program only found 460,000 TB+ (44%)  Very High Missing Cases Of those found, 97% are still on treatment and 92% successfully treated.
3,000 Multi-Drug Resistent notified (only 50%) of estimated 6,000 MDR cases, and only 57% treatment compliant.
MDR TB drugs still provided by Global Fund

6. Current Status Malaria by end 2017
Malaria is well on the way to elimination
266 of 516 districts (51%) already in Eliminated Status; 216 districts (41.8%) in process toward Elimination; and only 34 districts (6.5%) still high endemic, mostly in Eastern Indonesia
97% of all cases already confirmed with Lab test (RDT and Microscopy)
96% of all Malaria cases are treated with ACT.
GoI co-funding already achieved 75%

7. Summary of Indonesia Situation & Conclusions
TB is still a very significant threat for Indonesia and the world
HIV-AIDS is still a significant threat for Indonesia
TB and HIV programs quite strong in health service but definitely needs much improvement in Outreach  CSO roles
Malaria is well on the way to elimination
Conclusions :
Global Fund support still needed for TB and HIV after GF is needed to improve “Outreach” for both TB and HIV, especially to strengthen CSOs who do outreach and which has been the major role of Global Funds support in Indonesia.
Malaria program is ready for transition from GF support after 2020.
Let me end wiith some conclusions

8. Thank You Terima Kasih
CCM Indonesia